nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—ABCB1—esophageal cancer	0.412	1	CbGaD
Levofloxacin—SLC22A2—Cisplatin—esophageal cancer	0.125	0.547	CbGbCtD
Levofloxacin—SLC22A6—Methotrexate—esophageal cancer	0.0483	0.212	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—esophageal cancer	0.0332	0.146	CbGbCtD
Levofloxacin—ABCB1—Methotrexate—esophageal cancer	0.0215	0.0946	CbGbCtD
Levofloxacin—SLC22A4—larynx—esophageal cancer	0.0064	0.334	CbGeAlD
Levofloxacin—SLC22A4—neck—esophageal cancer	0.0017	0.0885	CbGeAlD
Levofloxacin—Sparfloxacin—ABCC2—esophageal cancer	0.00165	0.27	CrCbGaD
Levofloxacin—TOP2A—bronchus—esophageal cancer	0.00142	0.0741	CbGeAlD
Levofloxacin—Lomefloxacin—ABCC2—esophageal cancer	0.00136	0.222	CrCbGaD
Levofloxacin—SLC22A2—digestive system—esophageal cancer	0.00118	0.0617	CbGeAlD
Levofloxacin—Ofloxacin—ABCC2—esophageal cancer	0.00116	0.19	CrCbGaD
Levofloxacin—SLC22A4—bronchus—esophageal cancer	0.00114	0.0593	CbGeAlD
Levofloxacin—SLC22A4—trachea—esophageal cancer	0.00102	0.0532	CbGeAlD
Levofloxacin—Norfloxacin—CYP2A6—esophageal cancer	0.000931	0.152	CrCbGaD
Levofloxacin—TOP2A—lung—esophageal cancer	0.000917	0.0478	CbGeAlD
Levofloxacin—SLC22A4—digestive system—esophageal cancer	0.000879	0.0458	CbGeAlD
Levofloxacin—SLC22A4—lung—esophageal cancer	0.000734	0.0382	CbGeAlD
Levofloxacin—TOP2A—lymph node—esophageal cancer	0.000627	0.0327	CbGeAlD
Levofloxacin—Sparfloxacin—ABCB1—esophageal cancer	0.000607	0.0992	CrCbGaD
Levofloxacin—CYP1A2—digestive system—esophageal cancer	0.000527	0.0275	CbGeAlD
Levofloxacin—SLC22A4—lymph node—esophageal cancer	0.000502	0.0262	CbGeAlD
Levofloxacin—CYP1A2—lung—esophageal cancer	0.00044	0.0229	CbGeAlD
Levofloxacin—Ciprofloxacin—ABCB1—esophageal cancer	0.000413	0.0674	CrCbGaD
Levofloxacin—CYP3A4—digestive system—esophageal cancer	0.000381	0.0199	CbGeAlD
Levofloxacin—ABCB1—epithelium—esophageal cancer	0.000355	0.0185	CbGeAlD
Levofloxacin—Arrhythmia—Cisplatin—esophageal cancer	0.000343	0.00139	CcSEcCtD
Levofloxacin—Bronchitis—Capecitabine—esophageal cancer	0.00034	0.00138	CcSEcCtD
Levofloxacin—Alopecia—Cisplatin—esophageal cancer	0.000339	0.00137	CcSEcCtD
Levofloxacin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000339	0.00137	CcSEcCtD
Levofloxacin—Hepatic failure—Methotrexate—esophageal cancer	0.000338	0.00137	CcSEcCtD
Levofloxacin—Pancytopenia—Capecitabine—esophageal cancer	0.000335	0.00136	CcSEcCtD
Levofloxacin—Erythema—Cisplatin—esophageal cancer	0.000334	0.00135	CcSEcCtD
Levofloxacin—Malnutrition—Cisplatin—esophageal cancer	0.000334	0.00135	CcSEcCtD
Levofloxacin—Dysuria—Capecitabine—esophageal cancer	0.00033	0.00134	CcSEcCtD
Levofloxacin—Neutropenia—Capecitabine—esophageal cancer	0.00033	0.00134	CcSEcCtD
Levofloxacin—Renal failure acute—Methotrexate—esophageal cancer	0.000329	0.00134	CcSEcCtD
Levofloxacin—Flatulence—Cisplatin—esophageal cancer	0.000329	0.00133	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000328	0.00133	CcSEcCtD
Levofloxacin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000322	0.00131	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000322	0.00131	CcSEcCtD
Levofloxacin—Visual disturbance—Methotrexate—esophageal cancer	0.000321	0.0013	CcSEcCtD
Levofloxacin—Muscle spasms—Cisplatin—esophageal cancer	0.000321	0.0013	CcSEcCtD
Levofloxacin—Weight decreased—Capecitabine—esophageal cancer	0.000319	0.0013	CcSEcCtD
Levofloxacin—Hyperglycaemia—Capecitabine—esophageal cancer	0.000319	0.00129	CcSEcCtD
Levofloxacin—Pneumonia—Capecitabine—esophageal cancer	0.000317	0.00128	CcSEcCtD
Levofloxacin—Infestation NOS—Capecitabine—esophageal cancer	0.000315	0.00128	CcSEcCtD
Levofloxacin—Infestation—Capecitabine—esophageal cancer	0.000315	0.00128	CcSEcCtD
Levofloxacin—Vision blurred—Cisplatin—esophageal cancer	0.000315	0.00128	CcSEcCtD
Levofloxacin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000314	0.00127	CcSEcCtD
Levofloxacin—ABCB1—trachea—esophageal cancer	0.000314	0.0163	CbGeAlD
Levofloxacin—Tremor—Cisplatin—esophageal cancer	0.000313	0.00127	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000312	0.00127	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00031	0.00126	CcSEcCtD
Levofloxacin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00031	0.00126	CcSEcCtD
Levofloxacin—Ill-defined disorder—Cisplatin—esophageal cancer	0.00031	0.00126	CcSEcCtD
Levofloxacin—Renal failure—Capecitabine—esophageal cancer	0.000309	0.00125	CcSEcCtD
Levofloxacin—Myocardial infarction—Capecitabine—esophageal cancer	0.000309	0.00125	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000309	0.00125	CcSEcCtD
Levofloxacin—Anaemia—Cisplatin—esophageal cancer	0.000308	0.00125	CcSEcCtD
Levofloxacin—Jaundice—Capecitabine—esophageal cancer	0.000307	0.00124	CcSEcCtD
Levofloxacin—Stomatitis—Capecitabine—esophageal cancer	0.000307	0.00124	CcSEcCtD
Levofloxacin—Conjunctivitis—Capecitabine—esophageal cancer	0.000306	0.00124	CcSEcCtD
Levofloxacin—Osteoarthritis—Methotrexate—esophageal cancer	0.000304	0.00123	CcSEcCtD
Levofloxacin—Malaise—Cisplatin—esophageal cancer	0.000301	0.00122	CcSEcCtD
Levofloxacin—Haematuria—Capecitabine—esophageal cancer	0.0003	0.00122	CcSEcCtD
Levofloxacin—Leukopenia—Cisplatin—esophageal cancer	0.000299	0.00121	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000298	0.00121	CcSEcCtD
Levofloxacin—Epistaxis—Capecitabine—esophageal cancer	0.000297	0.0012	CcSEcCtD
Levofloxacin—Agranulocytosis—Capecitabine—esophageal cancer	0.000294	0.00119	CcSEcCtD
Levofloxacin—Mood swings—Methotrexate—esophageal cancer	0.000288	0.00117	CcSEcCtD
Levofloxacin—Bradycardia—Capecitabine—esophageal cancer	0.000288	0.00117	CcSEcCtD
Levofloxacin—Ataxia—Methotrexate—esophageal cancer	0.000286	0.00116	CcSEcCtD
Levofloxacin—Myalgia—Cisplatin—esophageal cancer	0.000284	0.00115	CcSEcCtD
Levofloxacin—Haemoglobin—Capecitabine—esophageal cancer	0.000284	0.00115	CcSEcCtD
Levofloxacin—Rhinitis—Capecitabine—esophageal cancer	0.000283	0.00115	CcSEcCtD
Levofloxacin—Anxiety—Cisplatin—esophageal cancer	0.000283	0.00115	CcSEcCtD
Levofloxacin—Haemorrhage—Capecitabine—esophageal cancer	0.000283	0.00115	CcSEcCtD
Levofloxacin—Hepatitis—Capecitabine—esophageal cancer	0.000283	0.00115	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000282	0.00114	CcSEcCtD
Levofloxacin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000281	0.00114	CcSEcCtD
Levofloxacin—Discomfort—Cisplatin—esophageal cancer	0.000281	0.00114	CcSEcCtD
Levofloxacin—Pharyngitis—Capecitabine—esophageal cancer	0.000281	0.00114	CcSEcCtD
Levofloxacin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000279	0.00113	CcSEcCtD
Levofloxacin—Oedema peripheral—Capecitabine—esophageal cancer	0.000278	0.00113	CcSEcCtD
Levofloxacin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000278	0.00113	CcSEcCtD
Levofloxacin—Urethral disorder—Capecitabine—esophageal cancer	0.000277	0.00112	CcSEcCtD
Levofloxacin—Breast disorder—Methotrexate—esophageal cancer	0.000275	0.00111	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000274	0.00111	CcSEcCtD
Levofloxacin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000272	0.0011	CcSEcCtD
Levofloxacin—Oedema—Cisplatin—esophageal cancer	0.000272	0.0011	CcSEcCtD
Levofloxacin—Visual impairment—Capecitabine—esophageal cancer	0.000272	0.0011	CcSEcCtD
Levofloxacin—Infection—Cisplatin—esophageal cancer	0.000271	0.0011	CcSEcCtD
Levofloxacin—ABCB1—digestive system—esophageal cancer	0.00027	0.0141	CbGeAlD
Levofloxacin—Erythema multiforme—Capecitabine—esophageal cancer	0.000267	0.00108	CcSEcCtD
Levofloxacin—Nervous system disorder—Cisplatin—esophageal cancer	0.000267	0.00108	CcSEcCtD
Levofloxacin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000267	0.00108	CcSEcCtD
Levofloxacin—Tachycardia—Cisplatin—esophageal cancer	0.000266	0.00108	CcSEcCtD
Levofloxacin—Skin disorder—Cisplatin—esophageal cancer	0.000265	0.00107	CcSEcCtD
Levofloxacin—Eye disorder—Capecitabine—esophageal cancer	0.000264	0.00107	CcSEcCtD
Levofloxacin—Tinnitus—Capecitabine—esophageal cancer	0.000264	0.00107	CcSEcCtD
Levofloxacin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000263	0.00107	CcSEcCtD
Levofloxacin—Asthma—Methotrexate—esophageal cancer	0.000263	0.00107	CcSEcCtD
Levofloxacin—Flushing—Capecitabine—esophageal cancer	0.000262	0.00106	CcSEcCtD
Levofloxacin—Cardiac disorder—Capecitabine—esophageal cancer	0.000262	0.00106	CcSEcCtD
Levofloxacin—Eosinophilia—Methotrexate—esophageal cancer	0.00026	0.00106	CcSEcCtD
Levofloxacin—Anorexia—Cisplatin—esophageal cancer	0.00026	0.00105	CcSEcCtD
Levofloxacin—Pancreatitis—Methotrexate—esophageal cancer	0.000258	0.00104	CcSEcCtD
Levofloxacin—Angiopathy—Capecitabine—esophageal cancer	0.000256	0.00104	CcSEcCtD
Levofloxacin—Immune system disorder—Capecitabine—esophageal cancer	0.000255	0.00103	CcSEcCtD
Levofloxacin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000255	0.00103	CcSEcCtD
Levofloxacin—Hypotension—Cisplatin—esophageal cancer	0.000255	0.00103	CcSEcCtD
Levofloxacin—Chills—Capecitabine—esophageal cancer	0.000254	0.00103	CcSEcCtD
Levofloxacin—Arrhythmia—Capecitabine—esophageal cancer	0.000252	0.00102	CcSEcCtD
Levofloxacin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000252	0.00102	CcSEcCtD
Levofloxacin—Alopecia—Capecitabine—esophageal cancer	0.00025	0.00101	CcSEcCtD
Levofloxacin—Pancytopenia—Methotrexate—esophageal cancer	0.00025	0.00101	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000248	0.00101	CcSEcCtD
Levofloxacin—Mental disorder—Capecitabine—esophageal cancer	0.000248	0.001	CcSEcCtD
Levofloxacin—Malnutrition—Capecitabine—esophageal cancer	0.000246	0.000997	CcSEcCtD
Levofloxacin—Erythema—Capecitabine—esophageal cancer	0.000246	0.000997	CcSEcCtD
Levofloxacin—Dysuria—Methotrexate—esophageal cancer	0.000246	0.000996	CcSEcCtD
Levofloxacin—Neutropenia—Methotrexate—esophageal cancer	0.000246	0.000996	CcSEcCtD
Levofloxacin—Paraesthesia—Cisplatin—esophageal cancer	0.000245	0.000992	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000244	0.00099	CcSEcCtD
Levofloxacin—Dyspnoea—Cisplatin—esophageal cancer	0.000243	0.000985	CcSEcCtD
Levofloxacin—Flatulence—Capecitabine—esophageal cancer	0.000242	0.000983	CcSEcCtD
Levofloxacin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000242	0.000981	CcSEcCtD
Levofloxacin—Dysgeusia—Capecitabine—esophageal cancer	0.000241	0.000977	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00024	0.000973	CcSEcCtD
Levofloxacin—Back pain—Capecitabine—esophageal cancer	0.000238	0.000965	CcSEcCtD
Levofloxacin—Decreased appetite—Cisplatin—esophageal cancer	0.000237	0.00096	CcSEcCtD
Levofloxacin—Muscle spasms—Capecitabine—esophageal cancer	0.000237	0.000959	CcSEcCtD
Levofloxacin—Pneumonia—Methotrexate—esophageal cancer	0.000236	0.000956	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000235	0.000953	CcSEcCtD
Levofloxacin—Infestation—Methotrexate—esophageal cancer	0.000234	0.00095	CcSEcCtD
Levofloxacin—Infestation NOS—Methotrexate—esophageal cancer	0.000234	0.00095	CcSEcCtD
Levofloxacin—Drowsiness—Methotrexate—esophageal cancer	0.000234	0.00095	CcSEcCtD
Levofloxacin—Pain—Cisplatin—esophageal cancer	0.000233	0.000944	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000232	0.000942	CcSEcCtD
Levofloxacin—Vision blurred—Capecitabine—esophageal cancer	0.000232	0.00094	CcSEcCtD
Levofloxacin—Tremor—Capecitabine—esophageal cancer	0.000231	0.000935	CcSEcCtD
Levofloxacin—Renal failure—Methotrexate—esophageal cancer	0.00023	0.000934	CcSEcCtD
Levofloxacin—Stomatitis—Methotrexate—esophageal cancer	0.000228	0.000926	CcSEcCtD
Levofloxacin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000228	0.000925	CcSEcCtD
Levofloxacin—Conjunctivitis—Methotrexate—esophageal cancer	0.000228	0.000924	CcSEcCtD
Levofloxacin—Anaemia—Capecitabine—esophageal cancer	0.000227	0.000922	CcSEcCtD
Levofloxacin—ABCB1—lung—esophageal cancer	0.000225	0.0117	CbGeAlD
Levofloxacin—Feeling abnormal—Cisplatin—esophageal cancer	0.000224	0.00091	CcSEcCtD
Levofloxacin—Haematuria—Methotrexate—esophageal cancer	0.000223	0.000906	CcSEcCtD
Levofloxacin—Malaise—Capecitabine—esophageal cancer	0.000222	0.000899	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000222	0.000899	CcSEcCtD
Levofloxacin—Epistaxis—Methotrexate—esophageal cancer	0.000221	0.000896	CcSEcCtD
Levofloxacin—Vertigo—Capecitabine—esophageal cancer	0.000221	0.000896	CcSEcCtD
Levofloxacin—Syncope—Capecitabine—esophageal cancer	0.000221	0.000894	CcSEcCtD
Levofloxacin—Leukopenia—Capecitabine—esophageal cancer	0.00022	0.000893	CcSEcCtD
Levofloxacin—Agranulocytosis—Methotrexate—esophageal cancer	0.000219	0.000887	CcSEcCtD
Levofloxacin—Palpitations—Capecitabine—esophageal cancer	0.000217	0.000881	CcSEcCtD
Levofloxacin—Loss of consciousness—Capecitabine—esophageal cancer	0.000216	0.000877	CcSEcCtD
Levofloxacin—Body temperature increased—Cisplatin—esophageal cancer	0.000215	0.000873	CcSEcCtD
Levofloxacin—Cough—Capecitabine—esophageal cancer	0.000215	0.00087	CcSEcCtD
Levofloxacin—Hypertension—Capecitabine—esophageal cancer	0.000212	0.000861	CcSEcCtD
Levofloxacin—Haemoglobin—Methotrexate—esophageal cancer	0.000211	0.000857	CcSEcCtD
Levofloxacin—Hepatitis—Methotrexate—esophageal cancer	0.00021	0.000853	CcSEcCtD
Levofloxacin—Haemorrhage—Methotrexate—esophageal cancer	0.00021	0.000853	CcSEcCtD
Levofloxacin—Arthralgia—Capecitabine—esophageal cancer	0.000209	0.000849	CcSEcCtD
Levofloxacin—Myalgia—Capecitabine—esophageal cancer	0.000209	0.000849	CcSEcCtD
Levofloxacin—Chest pain—Capecitabine—esophageal cancer	0.000209	0.000849	CcSEcCtD
Levofloxacin—Pharyngitis—Methotrexate—esophageal cancer	0.000209	0.000847	CcSEcCtD
Levofloxacin—Anxiety—Capecitabine—esophageal cancer	0.000209	0.000846	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000208	0.000843	CcSEcCtD
Levofloxacin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000208	0.000842	CcSEcCtD
Levofloxacin—Discomfort—Capecitabine—esophageal cancer	0.000207	0.000839	CcSEcCtD
Levofloxacin—Urethral disorder—Methotrexate—esophageal cancer	0.000206	0.000836	CcSEcCtD
Levofloxacin—Dry mouth—Capecitabine—esophageal cancer	0.000205	0.00083	CcSEcCtD
Levofloxacin—Visual impairment—Methotrexate—esophageal cancer	0.000203	0.000822	CcSEcCtD
Levofloxacin—Confusional state—Capecitabine—esophageal cancer	0.000202	0.000821	CcSEcCtD
Levofloxacin—Oedema—Capecitabine—esophageal cancer	0.000201	0.000814	CcSEcCtD
Levofloxacin—Hypersensitivity—Cisplatin—esophageal cancer	0.000201	0.000814	CcSEcCtD
Levofloxacin—Infection—Capecitabine—esophageal cancer	0.000199	0.000809	CcSEcCtD
Levofloxacin—Erythema multiforme—Methotrexate—esophageal cancer	0.000199	0.000806	CcSEcCtD
Levofloxacin—Shock—Capecitabine—esophageal cancer	0.000198	0.000801	CcSEcCtD
Levofloxacin—Nervous system disorder—Capecitabine—esophageal cancer	0.000197	0.000798	CcSEcCtD
Levofloxacin—Eye disorder—Methotrexate—esophageal cancer	0.000197	0.000797	CcSEcCtD
Levofloxacin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000197	0.000797	CcSEcCtD
Levofloxacin—Tinnitus—Methotrexate—esophageal cancer	0.000196	0.000795	CcSEcCtD
Levofloxacin—Tachycardia—Capecitabine—esophageal cancer	0.000196	0.000794	CcSEcCtD
Levofloxacin—Asthenia—Cisplatin—esophageal cancer	0.000195	0.000792	CcSEcCtD
Levofloxacin—Cardiac disorder—Methotrexate—esophageal cancer	0.000195	0.000792	CcSEcCtD
Levofloxacin—Skin disorder—Capecitabine—esophageal cancer	0.000195	0.000791	CcSEcCtD
Levofloxacin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000194	0.000787	CcSEcCtD
Levofloxacin—Anorexia—Capecitabine—esophageal cancer	0.000191	0.000776	CcSEcCtD
Levofloxacin—Angiopathy—Methotrexate—esophageal cancer	0.000191	0.000774	CcSEcCtD
Levofloxacin—Immune system disorder—Methotrexate—esophageal cancer	0.00019	0.00077	CcSEcCtD
Levofloxacin—Mediastinal disorder—Methotrexate—esophageal cancer	0.00019	0.000769	CcSEcCtD
Levofloxacin—Chills—Methotrexate—esophageal cancer	0.000189	0.000765	CcSEcCtD
Levofloxacin—Hypotension—Capecitabine—esophageal cancer	0.000188	0.000761	CcSEcCtD
Levofloxacin—Diarrhoea—Cisplatin—esophageal cancer	0.000186	0.000756	CcSEcCtD
Levofloxacin—Alopecia—Methotrexate—esophageal cancer	0.000186	0.000754	CcSEcCtD
Levofloxacin—Mental disorder—Methotrexate—esophageal cancer	0.000184	0.000747	CcSEcCtD
Levofloxacin—Erythema—Methotrexate—esophageal cancer	0.000183	0.000743	CcSEcCtD
Levofloxacin—Malnutrition—Methotrexate—esophageal cancer	0.000183	0.000743	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000183	0.000742	CcSEcCtD
Levofloxacin—Insomnia—Capecitabine—esophageal cancer	0.000182	0.000736	CcSEcCtD
Levofloxacin—Paraesthesia—Capecitabine—esophageal cancer	0.00018	0.000731	CcSEcCtD
Levofloxacin—Dysgeusia—Methotrexate—esophageal cancer	0.000179	0.000727	CcSEcCtD
Levofloxacin—Dyspnoea—Capecitabine—esophageal cancer	0.000179	0.000726	CcSEcCtD
Levofloxacin—Back pain—Methotrexate—esophageal cancer	0.000177	0.000718	CcSEcCtD
Levofloxacin—Dyspepsia—Capecitabine—esophageal cancer	0.000177	0.000717	CcSEcCtD
Levofloxacin—Decreased appetite—Capecitabine—esophageal cancer	0.000175	0.000708	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000173	0.000703	CcSEcCtD
Levofloxacin—Vomiting—Cisplatin—esophageal cancer	0.000173	0.000702	CcSEcCtD
Levofloxacin—Fatigue—Capecitabine—esophageal cancer	0.000173	0.000702	CcSEcCtD
Levofloxacin—Vision blurred—Methotrexate—esophageal cancer	0.000173	0.0007	CcSEcCtD
Levofloxacin—Rash—Cisplatin—esophageal cancer	0.000172	0.000696	CcSEcCtD
Levofloxacin—Pain—Capecitabine—esophageal cancer	0.000172	0.000696	CcSEcCtD
Levofloxacin—Constipation—Capecitabine—esophageal cancer	0.000172	0.000696	CcSEcCtD
Levofloxacin—Dermatitis—Cisplatin—esophageal cancer	0.000172	0.000696	CcSEcCtD
Levofloxacin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00017	0.000689	CcSEcCtD
Levofloxacin—Anaemia—Methotrexate—esophageal cancer	0.000169	0.000686	CcSEcCtD
Levofloxacin—Feeling abnormal—Capecitabine—esophageal cancer	0.000165	0.000671	CcSEcCtD
Levofloxacin—Malaise—Methotrexate—esophageal cancer	0.000165	0.00067	CcSEcCtD
Levofloxacin—Vertigo—Methotrexate—esophageal cancer	0.000165	0.000667	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000164	0.000666	CcSEcCtD
Levofloxacin—Leukopenia—Methotrexate—esophageal cancer	0.000164	0.000665	CcSEcCtD
Levofloxacin—Nausea—Cisplatin—esophageal cancer	0.000162	0.000656	CcSEcCtD
Levofloxacin—Cough—Methotrexate—esophageal cancer	0.00016	0.000648	CcSEcCtD
Levofloxacin—Urticaria—Capecitabine—esophageal cancer	0.00016	0.000647	CcSEcCtD
Levofloxacin—Body temperature increased—Capecitabine—esophageal cancer	0.000159	0.000644	CcSEcCtD
Levofloxacin—Abdominal pain—Capecitabine—esophageal cancer	0.000159	0.000644	CcSEcCtD
Levofloxacin—Myalgia—Methotrexate—esophageal cancer	0.000156	0.000632	CcSEcCtD
Levofloxacin—Arthralgia—Methotrexate—esophageal cancer	0.000156	0.000632	CcSEcCtD
Levofloxacin—Chest pain—Methotrexate—esophageal cancer	0.000156	0.000632	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000155	0.000628	CcSEcCtD
Levofloxacin—ABCB1—lymph node—esophageal cancer	0.000154	0.00803	CbGeAlD
Levofloxacin—Discomfort—Methotrexate—esophageal cancer	0.000154	0.000625	CcSEcCtD
Levofloxacin—Confusional state—Methotrexate—esophageal cancer	0.000151	0.000611	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000149	0.000606	CcSEcCtD
Levofloxacin—Infection—Methotrexate—esophageal cancer	0.000149	0.000602	CcSEcCtD
Levofloxacin—Hypersensitivity—Capecitabine—esophageal cancer	0.000148	0.0006	CcSEcCtD
Levofloxacin—Nervous system disorder—Methotrexate—esophageal cancer	0.000147	0.000594	CcSEcCtD
Levofloxacin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000146	0.000593	CcSEcCtD
Levofloxacin—Skin disorder—Methotrexate—esophageal cancer	0.000145	0.000589	CcSEcCtD
Levofloxacin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000145	0.000586	CcSEcCtD
Levofloxacin—Asthenia—Capecitabine—esophageal cancer	0.000144	0.000584	CcSEcCtD
Levofloxacin—Anorexia—Methotrexate—esophageal cancer	0.000142	0.000578	CcSEcCtD
Levofloxacin—Pruritus—Capecitabine—esophageal cancer	0.000142	0.000576	CcSEcCtD
Levofloxacin—Hypotension—Methotrexate—esophageal cancer	0.00014	0.000566	CcSEcCtD
Levofloxacin—Diarrhoea—Capecitabine—esophageal cancer	0.000137	0.000557	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000136	0.000552	CcSEcCtD
Levofloxacin—Insomnia—Methotrexate—esophageal cancer	0.000135	0.000548	CcSEcCtD
Levofloxacin—Paraesthesia—Methotrexate—esophageal cancer	0.000134	0.000544	CcSEcCtD
Levofloxacin—Dyspnoea—Methotrexate—esophageal cancer	0.000133	0.00054	CcSEcCtD
Levofloxacin—Somnolence—Methotrexate—esophageal cancer	0.000133	0.000539	CcSEcCtD
Levofloxacin—Dizziness—Capecitabine—esophageal cancer	0.000133	0.000538	CcSEcCtD
Levofloxacin—Dyspepsia—Methotrexate—esophageal cancer	0.000132	0.000533	CcSEcCtD
Levofloxacin—Decreased appetite—Methotrexate—esophageal cancer	0.00013	0.000527	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000129	0.000523	CcSEcCtD
Levofloxacin—Fatigue—Methotrexate—esophageal cancer	0.000129	0.000522	CcSEcCtD
Levofloxacin—Pain—Methotrexate—esophageal cancer	0.000128	0.000518	CcSEcCtD
Levofloxacin—Vomiting—Capecitabine—esophageal cancer	0.000128	0.000518	CcSEcCtD
Levofloxacin—Rash—Capecitabine—esophageal cancer	0.000127	0.000513	CcSEcCtD
Levofloxacin—Dermatitis—Capecitabine—esophageal cancer	0.000126	0.000513	CcSEcCtD
Levofloxacin—Headache—Capecitabine—esophageal cancer	0.000126	0.00051	CcSEcCtD
Levofloxacin—Feeling abnormal—Methotrexate—esophageal cancer	0.000123	0.000499	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000122	0.000496	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000122	0.00139	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000122	0.00138	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000121	0.00138	CbGpPWpGaD
Levofloxacin—Nausea—Capecitabine—esophageal cancer	0.000119	0.000484	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	0.000119	0.00135	CbGpPWpGaD
Levofloxacin—Urticaria—Methotrexate—esophageal cancer	0.000119	0.000481	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000119	0.00135	CbGpPWpGaD
Levofloxacin—Body temperature increased—Methotrexate—esophageal cancer	0.000118	0.000479	CcSEcCtD
Levofloxacin—Abdominal pain—Methotrexate—esophageal cancer	0.000118	0.000479	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—BUB1B—esophageal cancer	0.000117	0.00133	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	0.000117	0.00133	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000116	0.00132	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000116	0.00132	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000115	0.0013	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CHEK2—esophageal cancer	0.000112	0.00127	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000112	0.00127	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.000111	0.00126	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Methotrexate—esophageal cancer	0.00011	0.000446	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000109	0.00124	CbGpPWpGaD
Levofloxacin—Asthenia—Methotrexate—esophageal cancer	0.000107	0.000435	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000107	0.00122	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000107	0.00121	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000106	0.00121	CbGpPWpGaD
Levofloxacin—Pruritus—Methotrexate—esophageal cancer	0.000106	0.000429	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000105	0.00119	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000104	0.00118	CbGpPWpGaD
Levofloxacin—Diarrhoea—Methotrexate—esophageal cancer	0.000102	0.000415	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000101	0.00115	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.0001	0.00114	CbGpPWpGaD
Levofloxacin—Dizziness—Methotrexate—esophageal cancer	9.88e-05	0.000401	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	9.88e-05	0.00112	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	9.77e-05	0.00111	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	9.75e-05	0.00111	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	9.71e-05	0.0011	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	9.64e-05	0.0011	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.56e-05	0.00109	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	9.52e-05	0.00108	CbGpPWpGaD
Levofloxacin—Vomiting—Methotrexate—esophageal cancer	9.5e-05	0.000385	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—CASP8—esophageal cancer	9.49e-05	0.00108	CbGpPWpGaD
Levofloxacin—Rash—Methotrexate—esophageal cancer	9.42e-05	0.000382	CcSEcCtD
Levofloxacin—Dermatitis—Methotrexate—esophageal cancer	9.42e-05	0.000382	CcSEcCtD
Levofloxacin—Headache—Methotrexate—esophageal cancer	9.36e-05	0.00038	CcSEcCtD
Levofloxacin—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	9.26e-05	0.00105	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	9.23e-05	0.00105	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	9.19e-05	0.00104	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	9.12e-05	0.00104	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	9.06e-05	0.00103	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	8.94e-05	0.00102	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	8.91e-05	0.00101	CbGpPWpGaD
Levofloxacin—Nausea—Methotrexate—esophageal cancer	8.88e-05	0.00036	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.67e-05	0.000985	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	8.65e-05	0.000982	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—BLVRB—esophageal cancer	8.52e-05	0.000968	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC52A3—esophageal cancer	8.52e-05	0.000968	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	8.5e-05	0.000965	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	8.45e-05	0.00096	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	8.4e-05	0.000955	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	8.32e-05	0.000945	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	8.22e-05	0.000934	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	8.22e-05	0.000933	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.94e-05	0.000902	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	7.92e-05	0.000899	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	7.92e-05	0.000899	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	7.53e-05	0.000855	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	7.49e-05	0.000851	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	7.43e-05	0.000844	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	7.36e-05	0.000835	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	7.25e-05	0.000824	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CA1—esophageal cancer	7.24e-05	0.000823	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC10A2—esophageal cancer	7.24e-05	0.000823	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	7.2e-05	0.000818	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.19e-05	0.000816	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.17e-05	0.000814	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	7.13e-05	0.00081	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	7.12e-05	0.000809	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	7.09e-05	0.000806	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	7.04e-05	0.0008	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	6.98e-05	0.000792	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	6.92e-05	0.000785	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	6.9e-05	0.000784	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	6.9e-05	0.000784	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.89e-05	0.000782	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.89e-05	0.000782	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	6.83e-05	0.000776	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	6.82e-05	0.000775	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	6.75e-05	0.000767	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	6.75e-05	0.000767	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.68e-05	0.000758	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CA2—esophageal cancer	6.63e-05	0.000753	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	6.63e-05	0.000753	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	6.6e-05	0.00075	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.34e-05	0.00072	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADH7—esophageal cancer	6.16e-05	0.0007	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PLCE1—esophageal cancer	6.16e-05	0.0007	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RB1—esophageal cancer	6.11e-05	0.000694	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.08e-05	0.000691	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	6e-05	0.000682	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.68e-05	0.000645	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.6e-05	0.000636	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADH1B—esophageal cancer	5.4e-05	0.000613	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	5.37e-05	0.00061	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5.34e-05	0.000606	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.28e-05	0.0006	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	5.26e-05	0.000598	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.22e-05	0.000593	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TYMP—esophageal cancer	5.16e-05	0.000586	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	5.07e-05	0.000576	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.07e-05	0.000576	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP26A1—esophageal cancer	5.02e-05	0.00057	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	4.91e-05	0.000557	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALOX15—esophageal cancer	4.89e-05	0.000556	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.79e-05	0.000544	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.74e-05	0.000538	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.68e-05	0.000532	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	4.67e-05	0.00053	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TPI1—esophageal cancer	4.67e-05	0.00053	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTO1—esophageal cancer	4.67e-05	0.00053	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.66e-05	0.00053	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—BLVRB—esophageal cancer	4.65e-05	0.000529	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC52A3—esophageal cancer	4.65e-05	0.000529	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND1—esophageal cancer	4.54e-05	0.000515	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALDOB—esophageal cancer	4.48e-05	0.000508	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	4.39e-05	0.000498	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GAPDH—esophageal cancer	4.31e-05	0.000489	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CRABP1—esophageal cancer	4.27e-05	0.000485	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.18e-05	0.000475	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—EP300—esophageal cancer	4.17e-05	0.000474	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	4.07e-05	0.000462	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.07e-05	0.000462	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GNG7—esophageal cancer	4.06e-05	0.000461	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.02e-05	0.000457	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA1—esophageal cancer	3.96e-05	0.000449	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.96e-05	0.000449	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.91e-05	0.000444	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.82e-05	0.000434	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALDH2—esophageal cancer	3.81e-05	0.000432	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.72e-05	0.000422	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.72e-05	0.000422	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—esophageal cancer	3.64e-05	0.000413	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA2—esophageal cancer	3.62e-05	0.000411	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—esophageal cancer	3.62e-05	0.000411	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2A6—esophageal cancer	3.58e-05	0.000406	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.45e-05	0.000392	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ENO1—esophageal cancer	3.39e-05	0.000385	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS1—esophageal cancer	3.39e-05	0.000385	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.39e-05	0.000385	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PLCE1—esophageal cancer	3.37e-05	0.000382	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADH7—esophageal cancer	3.37e-05	0.000382	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PSME2—esophageal cancer	3.34e-05	0.00038	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PSME1—esophageal cancer	3.34e-05	0.00038	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.34e-05	0.000379	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.32e-05	0.000377	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.18e-05	0.000361	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	3.16e-05	0.000359	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA1—esophageal cancer	3.16e-05	0.000359	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—esophageal cancer	2.99e-05	0.000339	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADH1B—esophageal cancer	2.95e-05	0.000335	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA2—esophageal cancer	2.89e-05	0.000328	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.89e-05	0.000328	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1B1—esophageal cancer	2.88e-05	0.000328	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.87e-05	0.000326	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.87e-05	0.000326	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.82e-05	0.000321	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TYMP—esophageal cancer	2.82e-05	0.00032	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.77e-05	0.000314	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.74e-05	0.000312	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP19A1—esophageal cancer	2.71e-05	0.000308	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.71e-05	0.000307	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADH7—esophageal cancer	2.69e-05	0.000305	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.69e-05	0.000305	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALOX15—esophageal cancer	2.67e-05	0.000304	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.66e-05	0.000302	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TPI1—esophageal cancer	2.55e-05	0.00029	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTO1—esophageal cancer	2.55e-05	0.00029	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—HMOX1—esophageal cancer	2.47e-05	0.000281	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALDOB—esophageal cancer	2.45e-05	0.000278	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA1—esophageal cancer	2.44e-05	0.000277	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.44e-05	0.000277	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCB1—esophageal cancer	2.38e-05	0.00027	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.36e-05	0.000268	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GAPDH—esophageal cancer	2.35e-05	0.000267	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.35e-05	0.000267	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CRABP1—esophageal cancer	2.33e-05	0.000265	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.27e-05	0.000258	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TYMP—esophageal cancer	2.25e-05	0.000256	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA2—esophageal cancer	2.23e-05	0.000253	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GNG7—esophageal cancer	2.22e-05	0.000252	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.19e-05	0.000249	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.13e-05	0.000242	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALDH2—esophageal cancer	2.08e-05	0.000236	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADH7—esophageal cancer	2.07e-05	0.000235	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.07e-05	0.000235	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.04e-05	0.000231	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TPI1—esophageal cancer	2.04e-05	0.000231	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTT1—esophageal cancer	1.98e-05	0.000225	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.95e-05	0.000222	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.95e-05	0.000222	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.88e-05	0.000213	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.86e-05	0.000211	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS1—esophageal cancer	1.85e-05	0.00021	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ENO1—esophageal cancer	1.85e-05	0.00021	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.85e-05	0.00021	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PSME1—esophageal cancer	1.83e-05	0.000207	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PSME2—esophageal cancer	1.83e-05	0.000207	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.82e-05	0.000206	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GNG7—esophageal cancer	1.77e-05	0.000201	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TYMP—esophageal cancer	1.74e-05	0.000197	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.69e-05	0.000192	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.66e-05	0.000188	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.65e-05	0.000187	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CREBBP—esophageal cancer	1.59e-05	0.00018	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.58e-05	0.000179	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.58e-05	0.000179	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.57e-05	0.000178	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TPI1—esophageal cancer	1.57e-05	0.000178	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.56e-05	0.000177	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.55e-05	0.000177	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.51e-05	0.000171	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.48e-05	0.000168	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ENO1—esophageal cancer	1.48e-05	0.000168	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.48e-05	0.000168	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PSME1—esophageal cancer	1.46e-05	0.000166	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PSME2—esophageal cancer	1.46e-05	0.000166	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.45e-05	0.000165	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.44e-05	0.000163	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NOS3—esophageal cancer	1.42e-05	0.000161	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.37e-05	0.000155	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HMOX1—esophageal cancer	1.35e-05	0.000154	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—esophageal cancer	1.3e-05	0.000148	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.28e-05	0.000145	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.27e-05	0.000145	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.26e-05	0.000143	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.22e-05	0.000138	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.2e-05	0.000137	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.18e-05	0.000134	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.14e-05	0.00013	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.14e-05	0.00013	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.12e-05	0.000128	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.12e-05	0.000128	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—EP300—esophageal cancer	1.08e-05	0.000123	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.08e-05	0.000123	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.06e-05	0.00012	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.04e-05	0.000118	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.71e-06	0.00011	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.13e-06	0.000104	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CREBBP—esophageal cancer	8.67e-06	9.85e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.33e-06	9.46e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—esophageal cancer	8e-06	9.08e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.99e-06	9.08e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.83e-06	8.89e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NOS3—esophageal cancer	7.76e-06	8.82e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—esophageal cancer	7.1e-06	8.06e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.92e-06	7.86e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NOS3—esophageal cancer	6.2e-06	7.04e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—EP300—esophageal cancer	5.91e-06	6.71e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.67e-06	6.44e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.34e-06	6.07e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NOS3—esophageal cancer	4.78e-06	5.43e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—EP300—esophageal cancer	4.71e-06	5.35e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.38e-06	4.97e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.37e-06	4.96e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—EP300—esophageal cancer	3.64e-06	4.13e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.49e-06	3.96e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.69e-06	3.06e-05	CbGpPWpGaD
